<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03970317</url>
  </required_header>
  <id_info>
    <org_study_id>BBLCIP001</org_study_id>
    <nct_id>NCT03970317</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Broad Band Light In Motion Treatment</brief_title>
  <official_title>Characterization of Safety and Efficacy of Broad Band Light In Motion Treatment for Pigmented Skin Lesions on Chest, Arms and Back</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sciton</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sciton</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluate safety and efficacy of Broad Band Light (BBL) motion technique treatment for
      pigmentation, skin tone and texture
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2019</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Photographs</measure>
    <time_frame>6 weeks</time_frame>
    <description>Evaluation of Photographs using Physician's Global Assessment Scale (0-4) where 0 is no change and 4 is very significant improvement</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Pigmentation</condition>
  <arm_group>
    <arm_group_label>Broad Band Light</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Broad Band Light (BBL) motion treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Broad Band Light</intervention_name>
    <description>Broad Band Light Device</description>
    <arm_group_label>Broad Band Light</arm_group_label>
    <other_name>BBL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female, 18 years or older

          -  Fitzpatrick skin type I-V

          -  Has visible signs of moderate to severe skin pigmentation

          -  Subject must agree to not make any changes in their skin regimen for the duration of
             the study, including the follow-up period

          -  Subject must be able to read, understand and sign Informed Consent Form

          -  Willing to have digital photographs taken of the treatment area and agree to use of
             photographs for presentation, educational or marketing purposes

          -  Willing to have very limited sun exposure and use an approved sunscreen of SPF 50 or
             higher on the treatment area every day for the duration of the study, including the
             follow-up period

          -  Must be willing to adhere to the treatment and follow-up schedule and post-treatment
             care instructions

          -  Agree to not use any other procedure(s) in the treatment area during the study, such
             as laser- or light-based treatment, non-light based device treatment such as
             radiofrequency or ultrasound, injection of botulinum toxin, collagen, hyaluronic acid
             filler or other dermal filler, chemical peel, or surgical procedure

          -  Post-menopausal or surgically sterilized, or using a medically acceptable form of
             birth control at least 3 months prior to enrollment and during the entire course of
             the study, and no plans to become pregnant or to father a child for the duration of
             the study

        Exclusion Criteria:

          -  Participation in a clinical trial of another device or drug within 6 months prior to
             enrollment or during the study.

          -  Any type of prior cosmetic treatment to the target area within 3 months of study
             participation, such as laser or light-based procedures or surgery.

          -  Prior injection of botulinum toxin, collagen, hyaluronic acid filler or other dermal
             filler in the target area within 1 week of study participation.

          -  History of malignant tumors in the target area.

          -  Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, scars, large
             moles.

          -  Pregnant and/or breastfeeding.

          -  Having an infection, dermatitis or a rash in the treatment area.

          -  Significant concurrent illness, such as diabetes mellitus or cardiovascular disease,
             e.g., uncontrolled hypertension.

          -  Suffering from coagulation disorders or taking prescription anticoagulation
             medications.

          -  History of keloid scarring, hypertrophic scarring or of abnormal wound healing.

          -  History of immunosuppression/immune deficiency disorders or currently using
             immunosuppressive medications.

          -  History of vitiligo, eczema, or psoriasis.

          -  History of connective tissue disease, such as systemic lupus erythematosus or
             scleroderma.

          -  History of seizure disorders due to light.

          -  Any use of medication that is known to increase sensitivity to light according to
             Investigator's discretion.

          -  History of disease stimulated by heat, such as recurrent herpes simplex and/or herpes
             zoster (shingles) in the treatment area, unless treatment is conducted following a
             prophylactic regimen.

          -  History of radiation to the treatment area or undergoing systemic chemotherapy for the
             treatment of cancer.

          -  History of pigmentary disorders, particularly tendency for hyper- or hypo-
             pigmentation.

          -  Systemic use of retinoid, such as isotretinoin, or corticosteroid, as applicable,
             within 6 months of study participation.

          -  Topical use of retinoid, such as isotretinoin, corticosteroid or hydroquinone on the
             target area within 1 month of participation.

          -  Anytime in life, having have used gold therapy (gold salts) for disorders such as
             rheumatologic disease or lupus.

          -  Excessively tanned in areas to be treated, or unable/unlikely to refrain from tanning
             during the study (for example, subject's occupation requires regular sun exposure).

          -  Current smoker or history of smoking within 6 months of study participation.

          -  As per the Investigator's discretion, any physical or mental condition which might
             make it unsafe for the subject to participate in this study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sciton Inc</last_name>
    <phone>650-493-9155</phone>
    <email>clinicaltrials@sciton.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jay Patel</last_name>
    <phone>650-493-9155</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Refined Dermatology</name>
      <address>
        <city>Los Gatos</city>
        <state>California</state>
        <zip>95032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>408-688-2082</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>May 29, 2019</study_first_submitted>
  <study_first_submitted_qc>May 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 31, 2019</study_first_posted>
  <last_update_submitted>September 18, 2019</last_update_submitted>
  <last_update_submitted_qc>September 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

